Utilizing non-invasive prenatal test sequencing data for human genetic investigation

Cell Genom. 2024 Oct 9;4(10):100669. doi: 10.1016/j.xgen.2024.100669.

Abstract

Non-invasive prenatal testing (NIPT) employs ultra-low-pass sequencing of maternal plasma cell-free DNA to detect fetal trisomy. Its global adoption has established NIPT as a large human genetic resource for exploring genetic variations and their associations with phenotypes. Here, we present methods for analyzing large-scale, low-depth NIPT data, including customized algorithms and software for genetic variant detection, genotype imputation, family relatedness, population structure inference, and genome-wide association analysis of maternal genomes. Our results demonstrate accurate allele frequency estimation and high genotype imputation accuracy (R2>0.84) for NIPT sequencing depths from 0.1× to 0.3×. We also achieve effective classification of duplicates and first-degree relatives, along with robust principal-component analysis. Additionally, we obtain an R2>0.81 for estimating genetic effect sizes across genotyping and sequencing platforms with adequate sample sizes. These methods offer a robust theoretical and practical foundation for utilizing NIPT data in medical genetic research.

Keywords: NIPT-human-genetics workflow; allele frequency estimation; cell-free DNA; family relatedness; genome-wide association analysis; genotype imputation; low-pass whole-genome sequencing; non-invasive prenatal test; population structure; variant detection.

MeSH terms

  • Algorithms
  • Female
  • Gene Frequency
  • Genome-Wide Association Study* / methods
  • Genotype
  • Humans
  • Noninvasive Prenatal Testing / methods
  • Polymorphism, Single Nucleotide
  • Pregnancy
  • Prenatal Diagnosis / methods
  • Sequence Analysis, DNA / methods
  • Software